The use of amantadine in the prevention of progression and treatment of COVID-19 symptoms in patients infected with the SARS-CoV-2 virus (COV-PREVENT): Study rationale and design

BACKGROUND: COVID-19, a disease caused by infection with the SARS-CoV-2 virus, is asymptomatic or mildly symptomatic in most cases. Some patients, usually burdened with risk factors develop acute respiratory failure and other organ dysfunction. In such cases, the mortality rate is very high despite...

Descripción completa

Detalles Bibliográficos
Autores principales: Rejdak, Konrad, Fiedor, Piotr, Bonek, Robert, Goch, Aleksander, Gala-Błądzińska, Agnieszka, Chełstowski, Waldemar, Łukasiak, Jacek, Kiciak, Sławomir, Dąbrowski, Piotr, Dec, Mateusz, Król, Zbigniew J., Papuć, Ewa, Zasybska, Adriana, Segiet, Agnieszka, Grieb, Paweł
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978450/
https://www.ncbi.nlm.nih.gov/pubmed/35390511
http://dx.doi.org/10.1016/j.cct.2022.106755

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978450/
https://www.ncbi.nlm.nih.gov/pubmed/35390511
http://dx.doi.org/10.1016/j.cct.2022.106755

Ejemplares similares